Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 3 of 3 for “"astatine-211"”.

  1. Radioimmunotherapy of Metastatic Disease - Studies of Alpha- and Beta-particle-Emitting Radionuclides in a Preclinical Model

    … radionuclide (t½=6.7 days) and astatine-211 (211At) emits alpha particles (t½=7.2 h). These radionuclides were used to label a mAb targeting the Lewis Y antigen expressed on many carcinomas. A syngeneic rat colon carcinoma model was used in all the studies. The aim of the work …

    lund Repository record for Radioimmunotherapy of Metastatic Disease - Studies of Alpha- and Beta-particle-Emitting Radionuclides in a Preclinical Model (opens in a new tab)

  2. Microdosimetry of radiohalogens in thyroid models

    The radiohalogens 123I, 124I, 125I, 131I, and 211At are routinely used or proposed for diagnostic and therapeutic purposes. The different characteristics and application areas of these radioiodine isotopes, together with the possibility to bind them to the same carrier molecule, give many …

    goteborg Repository record for Microdosimetry of radiohalogens in thyroid models (opens in a new tab)

  3. Radiobiological effects of the thyroid gland - transcriptomic and proteomic responses to 131l and 211At exposure

    … halide to target the thyroid or thyroid cancer. 211At is proposed for radionuclide therapy and preclinical and clinical research on 211At-labeled tumor targeting molecules is on-going. The thyroid gland accumulates both 131I and 211At as halides and is an organ at risk. Additionally, 131I …

    goteborg Repository record for Radiobiological effects of the thyroid gland - transcriptomic and proteomic responses to 131l and 211At exposure (opens in a new tab)